Cargando…
Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein
In March 2003, a novel coronavirus was isolated from patients exhibiting atypical pneumonia and subsequently proven to be the causative agent of the disease now referred to as severe acute respiratory syndrome (SARS). The complete genome of the SARS coronavirus (SARS-CoV) has since been sequenced. T...
Autores principales: | He, Runtao, Leeson, Andrew, Andonov, Anton, Li, Yan, Bastien, Nathalie, Cao, Jingxin, Osiowy, Carla, Dobie, Frederick, Cutts, Todd, Ballantine, Melissa, Li, Xuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111052/ https://www.ncbi.nlm.nih.gov/pubmed/14623261 http://dx.doi.org/10.1016/j.bbrc.2003.10.075 |
Ejemplares similares
-
Analysis of multimerization of the SARS coronavirus nucleocapsid protein
por: He, Runtao, et al.
Publicado: (2004) -
Characterization of protein–protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus
por: He, Runtao, et al.
Publicado: (2004) -
Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid
por: He, Runtao, et al.
Publicado: (2004) -
Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy
por: Osiowy, Carla, et al.
Publicado: (2016) -
Erratum to “Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid” [Biochem. Biophys. Res. Commun. 320 (2004) 1199–1203]
por: He, Runtao, et al.
Publicado: (2004)